EGFR Expression in Primary Squamous Cell Carcinoma of the Thyroid

被引：10
作者：
Long, Jennifer L. [1 ]
Strocker, Ali M. [3 ]
Wang, Marilene B. [1 ,2 ]
Blackwell, Keith E. [1 ,2 ]
机构：
[1] Univ Calif Los Angeles, Div Head & Neck Surg, Los Angeles, CA 90024 USA
[2] Childrens Hosp Los Angeles, W Los Angeles Vet Affairs Med Ctr, Dept Otolaryngol, Los Angeles, CA 90027 USA
[3] Childrens Hosp Los Angeles, Dept Pediat Otolaryngol, Los Angeles, CA 90027 USA
来源：
LARYNGOSCOPE | 2009年 / 119卷 / 01期
关键词：
Thyroid; EGFR; squamous cell carcinoma; EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR;
D O I：
10.1002/lary.20062
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
We present the case of a 57-year-old male with primary squamous cell carcinoma of the thyroid (PSCCT). Epidermal growth factor receptor (EGFR) staining was strongly positive. Pharmaceuticals targeting EGFR may provide an additional therapeutic option for this rare disease with extremely poor prognosis.
引用
收藏
页码：89 / 90
页数：2
相关论文
共 8 条
  • [1] Primary squamous cell carcinoma of the thyroid: Report of ten cases
    Booya, F
    Sebo, TJ
    Kasperbauer, JL
    Fatourechi, V
    [J]. THYROID, 2006, 16 (01) : 89 - 93
  • [2] Epidermal growth factor receptor as a novel therapeutic target in anaplastic thyroid carcinomas
    Ensinger, C
    Spizzo, G
    Moser, P
    Tschoerner, I
    Prommegger, R
    Gabriel, M
    Mikuz, G
    Schmid, KW
    [J]. SIGNAL TRANSDUCTION PATHWAYS, CHROMATIN STRUCTURE, AND GENE EXPRESSION MECHANISMS AS THERAPEUTIC TARGETS, 2004, 1030 : 69 - 77
  • [3] EPIDERMAL GROWTH-FACTOR RECEPTORS IN PLASMA-MEMBRANES OF NORMAL AND DISEASED HUMAN THYROID-GLANDS
    KANAMORI, A
    ABE, Y
    YAJIMA, Y
    MANABE, Y
    ITO, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (05) : 899 - 903
  • [4] Epidermal growth factor receptor status in anaplastic thyroid carcinoma
    Lee, Dae Ho
    Lee, Geon Kook
    Kong, Sun-young
    Kook, Myoung Chul
    Yang, Sun Kyung
    Park, So Yeon
    Park, Seong Hoe
    Keam, Bhumsuk
    Park, Do Joon
    Cho, Bo Youn
    Kim, Seok Won
    Chung, Ki-Wook
    Lee, Eun Sook
    Kim, Sun Wook
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (08) : 881 - 884
  • [5] Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues
    Marti, U
    Ruchti, C
    Kämpf, J
    Thomas, GA
    Williams, ED
    Peter, HJ
    Gerber, H
    Bürgi, U
    [J]. THYROID, 2001, 11 (02) : 137 - 145
  • [6] Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: Implication for a new therapeutic approach
    Murakawa, T
    Tsuda, H
    Tanimoto, T
    Tanabe, T
    Kitahara, S
    Matsubara, O
    [J]. PATHOLOGY INTERNATIONAL, 2005, 55 (12) : 757 - 765
  • [7] Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer
    Schiff, BA
    McMurphy, AB
    Jasser, SA
    Younes, MN
    Doan, D
    Yigitbasi, OG
    Kim, SW
    Zhou, G
    Mandal, M
    Bekele, BN
    Holsinger, FC
    Sherman, SI
    Yeung, SC
    El-Naggar, AK
    Myers, JN
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8594 - 8602
  • [8] Anaplastic thyroid carcinoma: Expression profile of targets for therapy offers new insights for disease treatment
    Wiseman, Sam M.
    Masoudi, Hamid
    Niblock, Paddy
    Turbin, Dmitry
    Rajput, Ashish
    Hay, John
    Bugis, Samuel
    Filipenko, Douglas
    Huntsman, David
    Gilks, Blake
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 719 - 729
1